This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Yale University, University of Pittsburgh. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: The Innovations of Albert Ko
Introduction
Albert Ko is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of medical research, particularly in the detection and treatment of infections. With a total of 3 patents, his work has the potential to impact public health positively.
Latest Patents
Ko's latest patents include innovative methods and compositions for the detection of infections. One of his notable inventions involves detecting a recent infection by measuring the amount of anti-NS1 IgG3. Additionally, he has developed methods for detecting prior Dengue virus infections in subjects previously immunized with a Dengue virus vaccine. Another significant patent focuses on compositions and methods of preparing flagellar-coiling protein 1 (Fcp1)-deficient bacteria. This invention includes an isolated Fcp1-deficient bacterium and methods for producing motility-deficient bacteria. Furthermore, he has created methods for stimulating an immune response and treating infectious diseases caused by bacteria.
Career Highlights
Throughout his career, Albert Ko has worked with prestigious institutions such as Yale University and the University of Pittsburgh. His research has contributed to advancements in understanding and combating infectious diseases.
Collaborations
Ko has collaborated with notable colleagues, including Elsio Wunder and Ernesto Torres De Azeved Marques, Jr. Their combined expertise has furthered the impact of his research in the scientific community.
Conclusion
Albert Ko's innovative work in the field of infection detection and treatment showcases his dedication to improving public health. His patents reflect a commitment to advancing medical science and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

